ZURA
Zura Bio Ltd
NASDAQ · Healthcare · Biotechnology · US
$3.81
−1.80%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-43.5%
Return on equity
-40.2%
Return on assets
-47.1%
Return on invested capital
0.00x
Asset turnover
-$77.5M
Cash from operations
$2.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026